• Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts

    Source: Buzz FX / 03 Feb 2025 04:31:09   America/New_York


    Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat February 3, 2025 Share Link copied to clipboard. Shares of Mirum Pharmaceuticals, Inc.
    Read more...
Share on,